| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |